Mumbai, India

Krishna Baban Narawade


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Krishna Baban Narawade

Introduction

Krishna Baban Narawade, an inventive mind from Mumbai, India, has made significant contributions to the field of pharmaceutical chemistry. With a focus on the development of innovative processes, he has secured two patents that showcase his expertise and commitment to advancing medical science.

Latest Patents

His latest patents include a "Process for Preparation of Azelaic Acid," which outlines an efficient method for synthesizing this important compound used in dermatology. Additionally, Krishna has patented a "Process for Preparation of Fingolimod," a compound essential in the treatment of multiple sclerosis. This patent emphasizes the purification of the compound free from regioisomeric impurities, which is crucial for ensuring the integrity of pharmaceutical formulations.

Career Highlights

Krishna has built his career in reputable organizations including Glenmark Generics Limited and Glenmark Pharmaceuticals Limited. His work in these companies has allowed him to contribute to the development of breakthrough therapies and pharmaceutical products, earning him recognition in the field.

Collaborations

Throughout his journey, Krishna has collaborated with esteemed professionals such as Prem Chand and Shekhar Bhaskar Bhirud. These partnerships have enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

In conclusion, Krishna Baban Narawade is a notable inventor whose patents and professional contributions are vital in the pharmaceutical sector. His innovative processes not only reflect his technical proficiency but also his dedication to improving healthcare through science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…